Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
BRENTWOOD, Tenn., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the closing of its previously announced underwritten public offering of 6,900,000 shares of its common stock at a public offering price of $46.50 per share, which includes 900,000 shares of common stock issued upon the exercise, in full, by the underwriters of an option to purchase additional shares from Surgery Partners. The gross proceeds from the offering, before dedu
How far off is Surgery Partners, Inc. ( NASDAQ:SGRY ) from its intrinsic value? Using the most recent financial data...
BRENTWOOD, Tenn., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $46.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $279.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. I
BRENTWOOD, Tenn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock. The offering is subject to ma
SGRY earnings call for the period ending September 30, 2021.
Surgery Partners (SGRY) delivered earnings and revenue surprises of -25.00% and 0.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?